2017 American Transplant Congress
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.
1Infectious Diseases, Yale University, New Haven, CT; 2Pharmacy, YNHH, New Haven, CT
IntroductionCurrent guidelines on cytomegalovirus (CMV) prophylaxis following organ transplant recommend using valganciclovir (VGCV) 900 mg daily for high (CMV D+/R-) and intermediate (CMV R+) risk…2017 American Transplant Congress
BKV Clearance Time Correlates with T-Cell Receptor Repertoire Shape and Exhaustion State of BKV-Specific T-Cells in Renal Transplant Patients with Severe BKV Infection.
Reactivation of the BK polyomavirus is known to lead to severe complications in kidney transplant patients. The current treatment strategy relies on decreasing the immunosuppression…2017 American Transplant Congress
Molecular Significance of Peritubular Capillaritis in Early Transplant Kidney Biopsies of Donor-Specific Antibody Negative Patients.
Montefiore Medical Center Transplant Center, Albert Einstein College of Medicine, Bronx
Background: Peritubular capillaritis (PTC) is a part of microvascular inflammation seen in antibody-mediated rejection. However, it can be observed as an isolated lesion in early…2017 American Transplant Congress
Increased Pro-Inflammatory and Decreased Interferon-Related Gene Expression in Older as Compared with Younger Kidney Transplant Recipients.
David Geffen School of Medicine at UCLA, Los Angeles, CA
Older transplant recipients experience increased rates of death and infection as compared with younger patients. Our previous studies demonstrated increased frequency of terminally differentiated and…2017 American Transplant Congress
Predictive Value of Renal Transplant Scintigraphy for the Duration of Delayed Graft Function.
Background: Renal scintigraphy (RS) is a widely used test for the assessment of the transplanted kidney (KTX). As RS cannot reliably distinguish between rejection and…2017 American Transplant Congress
Understanding the Role of Induction Agents in Older versus Younger Kidney Transplant Recipients.
Johns Hopkins University, Baltimore, MD
Background: There has been an increase in the number of older (over 65) KT recipients. Aging-related changes such as differences in immune senescence may influence…2017 American Transplant Congress
Triptolide Alleviating Acute Antibody Mediated Rejection by Inhibition of B Cell Activation in Presensitized Recipients.
Backgroud: Acute antibody mediated rejection (AMR), resistant to most anti-rejection therapy, is main cause for renal graft loss. Triptolide(TPL) had been reported as a promising…2017 American Transplant Congress
Kidney Transplantation Outcomes from Donors with Acute Kidney Injury.
Abdominal Transplant Surgery, Montefiore Medical Center, Bronx, NY
Background- Organ scarcity and increased waiting times for kidney transplantation has led the transplant community to utilize more sub-optimal organs while continuing providing survival benefit…2017 American Transplant Congress
Increasing Living Donation by Implementing the Kidney Coach Program.
Recanati Miller Transplantation Institute, Mount Sinai Hospital, New York, NY
Introduction: It is firmly established that for patients requiring transplant, living donor kidney transplantation (LDKT) is better than deceased donor transplantation. However, recipients find it…2017 American Transplant Congress
Pregnancy Outcomes in Female Kidney Transplant Recipients Using Assisted Fertility Methods.
The purpose of this study was to analyze pregnancy and transplant outcomes in female kidney recipients who used fertility medications alone (FM), intrauterine insemination (IUI),…
- « Previous Page
- 1
- …
- 389
- 390
- 391
- 392
- 393
- …
- 531
- Next Page »